Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Long-Term Immunogenicity of the Norovirus GI.I/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Adults
Condition: Norovirus Intervention: Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine Sponsor: Takeda Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2017 Category: Research Source Type: clinical trials

Long-Term Immunogenicity of the Norovirus GI.I/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Adults
Condition: Norovirus Intervention: Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine Sponsor: Takeda Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2017 Category: Research Source Type: clinical trials

Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
Condition: Norovirus Gastroenteritis Interventions: Drug: VXA-G1.1-NN Oral Vaccine; Drug: VXA Placebo Tablets Sponsor: Vaxart Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2016 Category: Research Source Type: clinical trials